Akili releases EndeavorOTC for adults with ADHD symptoms

Akili today announced the official release of its new product, EndeavorOTC. The mobile game is a version of Akili’s similarly named, FDA-authorized EndeavorRX, built upon the same technology. But while EndeavorRX is available for children ages 8-12 with a prescription, EndeavorOTC is available for adults 18 and older without a prescription.

The developer recently announced that EndeavorOTC’s clinical trials revealed that it “improved focus, attention, and overall quality of life in adults struggling with ADHD symptoms.” 83% of participants reported an improvement in focus and 73% reported an improved quality of life and the ability to complete multiple tasks at once.